RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 140 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $55,000 | +5.8% | 46,755 | +0.9% | 0.00% | 0.0% |
| Q2 2022 | $52,000 | -62.3% | 46,343 | +0.3% | 0.00% | 0.0% |
| Q1 2022 | $138,000 | +13.1% | 46,226 | +0.5% | 0.00% | 0.0% |
| Q4 2021 | $122,000 | -27.4% | 45,984 | -0.8% | 0.00% | 0.0% |
| Q3 2021 | $168,000 | -15.6% | 46,351 | +0.9% | 0.00% | -50.0% |
| Q2 2021 | $199,000 | +18.5% | 45,934 | -6.6% | 0.00% | +100.0% |
| Q1 2021 | $168,000 | -1.8% | 49,191 | +0.5% | 0.00% | -50.0% |
| Q4 2020 | $171,000 | +40.2% | 48,943 | -3.8% | 0.00% | +100.0% |
| Q3 2020 | $122,000 | +74.3% | 50,862 | +33.7% | 0.00% | 0.0% |
| Q2 2020 | $70,000 | +14.8% | 38,047 | -3.3% | 0.00% | 0.0% |
| Q1 2020 | $61,000 | – | 39,349 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.02% |